share_log

JP Morgan Maintains Overweight on Cogent Biosciences, Raises Price Target to $20

Moomoo 24/7 ·  Feb 27 13:00

JP Morgan analyst Anupam Rama maintains Cogent Biosciences (NASDAQ:COGT) with a Overweight and raises the price target from $18 to $20.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment